A phase Ii trial of Neoadjuvant Ipilimumab follwed by Melphalan (L-PAM) via isolated Limb infusion (ILI) for patients wi

Administered By

Awarded By

Contributors

Start/End

  • February 1, 2014 - April 2, 2018